Contineum Therapeutics (CTNM) Current Leases: 2023-2025
Historic Current Leases for Contineum Therapeutics (CTNM) over the last 2 years, with Sep 2025 value amounting to $1.5 million.
- Contineum Therapeutics' Current Leases rose 141.73% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 141.73%. This contributed to the annual value of $1.5 million for FY2024, which is 212.93% up from last year.
- According to the latest figures from Q3 2025, Contineum Therapeutics' Current Leases is $1.5 million, which was up 0.75% from $1.5 million recorded in Q2 2025.
- Over the past 5 years, Contineum Therapeutics' Current Leases peaked at $1.5 million during Q3 2025, and registered a low of $464,000 during Q4 2023.
- Its 3-year average for Current Leases is $985,375, with a median of $1.0 million in 2024.
- Data for Contineum Therapeutics' Current Leases shows a peak YoY spiked of 212.93% (in 2024) over the last 5 years.
- Contineum Therapeutics' Current Leases (Quarterly) stood at $464,000 in 2023, then skyrocketed by 212.93% to $1.5 million in 2024, then surged by 141.73% to $1.5 million in 2025.
- Its Current Leases was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.